BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 11496185)

  • 1. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts.
    Chin GS; Liu W; Peled Z; Lee TY; Steinbrech DS; Hsu M; Longaker MT
    Plast Reconstr Surg; 2001 Aug; 108(2):423-9. PubMed ID: 11496185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the abrogation of TGF-beta1 by antisense oligonucleotides on the expression of TGF-beta-isoforms and their receptors I and II in isolated fibroblasts from keloid scars.
    Bran GM; Goessler UR; Schardt C; Hormann K; Riedel F; Sadick H
    Int J Mol Med; 2010 Jun; 25(6):915-21. PubMed ID: 20428796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking transforming growth factor-beta receptor signaling down-regulates transforming growth factor-beta1 autoproduction in keloid fibroblasts.
    Liu W; Cai Z; Wang D; Wu X; Cui L; Shang Q; Qian Y; Cao Y
    Chin J Traumatol; 2002 Apr; 5(2):77-81. PubMed ID: 11904067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions.
    Tsujita-Kyutoku M; Uehara N; Matsuoka Y; Kyutoku S; Ogawa Y; Tsubura A
    In Vivo; 2005; 19(6):959-63. PubMed ID: 16277007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
    Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR
    Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids.
    Lee TY; Chin GS; Kim WJ; Chau D; Gittes GK; Longaker MT
    Ann Plast Surg; 1999 Aug; 43(2):179-84. PubMed ID: 10454326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of elF3a inhibits TGF‑β1‑induced extracellular matrix protein expression in keloid fibroblasts.
    Li T; Zhao J
    Mol Med Rep; 2018 Mar; 17(3):4057-4061. PubMed ID: 29286129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
    Wu CS; Wu PH; Fang AH; Lan CC
    Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
    He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
    Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
    Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
    Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
    Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
    J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxymatrine inhibits collagen synthesis in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
    Fan DL; Zhao WJ; Wang YX; Han SY; Guo S
    Int J Dermatol; 2012 Apr; 51(4):463-72. PubMed ID: 22435440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
    Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
    Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of mRNA for transforming growth factor beta (TGF beta) and TGF beta receptors I and II and decreased TGF beta binding to the receptors in in vitro-aged fibroblasts.
    Mori Y; Hatamochi A; Arakawa M; Ueki H
    Arch Dermatol Res; 1998 Mar; 290(3):158-62. PubMed ID: 9558492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of TGF-beta, the TGF-beta type I receptor and the R-II receptor in peripheral nerves and mechanoreceptors; observations on changes after traumatic injury.
    Stark B; Carlstedt T; Risling M
    Brain Res; 2001 Sep; 913(1):47-56. PubMed ID: 11532246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling.
    Quan T; He T; Kang S; Voorhees JJ; Fisher GJ
    Am J Pathol; 2004 Sep; 165(3):741-51. PubMed ID: 15331399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts.
    Tang B; Zhu B; Liang Y; Bi L; Hu Z; Chen B; Zhang K; Zhu J
    Arch Dermatol Res; 2011 Oct; 303(8):563-72. PubMed ID: 21240513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts.
    Chu Y; Guo F; Li Y; Li X; Zhou T; Guo Y
    Connect Tissue Res; 2008; 49(2):92-8. PubMed ID: 18382895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.